Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/00 → 1/1/00 |
Funding
- Biogen Idec Incorporated: $10,430.77
Protocol No. 230LE301: A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus a
- Gibson, Bernard (PI)
Project: Other project